Literature DB >> 27942583

Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes.

Howard R Seay1, Erik Yusko2, Stephanie J Rothweiler1, Lin Zhang1, Amanda L Posgai1, Martha Campbell-Thompson1, Marissa Vignali2, Ryan O Emerson2, John S Kaddis3, Dave Ko3, Maki Nakayama4, Mia J Smith5, John C Cambier5, Alberto Pugliese6, Mark A Atkinson1, Harlan S Robins2,7, Todd M Brusko1.   

Abstract

The adaptive immune repertoire plays a critical role in type 1 diabetes (T1D) pathogenesis. However, efforts to characterize B cell and T cell receptor (TCR) profiles in T1D subjects have been largely limited to peripheral blood sampling and restricted to known antigens. To address this, we collected pancreatic draining lymph nodes (pLN), "irrelevant" nonpancreatic draining lymph nodes, peripheral blood mononuclear cells (PBMC), and splenocytes from T1D subjects (n = 18) and control donors (n = 9) as well as pancreatic islets from 1 T1D patient; from these tissues, we collected purified CD4+ conventional T cells (Tconv), CD4+ Treg, CD8+ T cells, and B cells. By conducting high-throughput immunosequencing of the TCR β chain (TRB) and B cell receptor (BCR) immunoglobulin heavy chain (IGH) on these samples, we sought to analyze the molecular signature of the lymphocyte populations within these tissues and of T1D. Ultimately, we observed a highly tissue-restricted CD4+ repertoire, while up to 24% of CD8+ clones were shared among tissues. We surveyed our data set for previously described proinsulin- and glutamic acid decarboxylase 65-reactive (GAD65-reactive) receptors, and interestingly, we observed a TRB with homology to a known GAD65-reactive TCR (clone GAD4.13) present in 7 T1D donors (38.9%), representing >25% of all productive TRB within Tconv isolated from the pLN of 1 T1D subject. These data demonstrate diverse receptor signatures at the nucleotide level and enriched autoreactive clones at the amino acid level, supporting the utility of coupling immunosequencing data with knowledge of characterized autoreactive receptors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27942583      PMCID: PMC5135280          DOI: 10.1172/jci.insight.88242

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  66 in total

1.  Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells.

Authors:  James E Greening; Timothy I M Tree; Karolena T Kotowicz; Astrid G van Halteren; Bart O Roep; Nigel J Klein; Mark Peakman
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

Review 2.  Organ donor specimens: What can they tell us about type 1 diabetes?

Authors:  Martha Campbell-Thompson
Journal:  Pediatr Diabetes       Date:  2015-05-22       Impact factor: 4.866

3.  Pancreatic biopsies in type 1 diabetes: revisiting the myth of Pandora's box.

Authors:  Mark A Atkinson
Journal:  Diabetologia       Date:  2014-01-19       Impact factor: 10.122

4.  Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.

Authors:  Sally C Kent; Yahua Chen; Lisa Bregoli; Sue M Clemmings; Norma Sue Kenyon; Camillo Ricordi; Bernhard J Hering; David A Hafler
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

5.  Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.

Authors:  Maki Nakayama; Kristen McDaniel; Lisa Fitzgerald-Miller; Carol Kiekhaefer; Janet K Snell-Bergeon; Howard W Davidson; Marian Rewers; Liping Yu; Peter Gottlieb; John W Kappler; Aaron Michels
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

6.  TCR bias of in vivo expanded T cells in pancreatic islets and spleen at the onset in human type 1 diabetes.

Authors:  Eva Codina-Busqueta; Erika Scholz; Pau M Muñoz-Torres; Carme Roura-Mir; Manuela Costa; Cristina Xufré; Raquel Planas; Marta Vives-Pi; Dolores Jaraquemada; Mercè Martí
Journal:  J Immunol       Date:  2011-02-16       Impact factor: 5.422

7.  The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse.

Authors:  L Shoda; H Kreuwel; K Gadkar; Y Zheng; C Whiting; M Atkinson; J Bluestone; D Mathis; D Young; S Ramanujan
Journal:  Clin Exp Immunol       Date:  2010-05-18       Impact factor: 4.330

8.  Flexible management of enzymatic digestion improves human islet isolation outcome from sub-optimal donor pancreata.

Authors:  A N Balamurugan; Yigang Chang; John J Fung; Massimo Trucco; Rita Bottino
Journal:  Am J Transplant       Date:  2003-09       Impact factor: 8.086

9.  Restricted autoantigen recognition associated with deletional and adaptive regulatory mechanisms.

Authors:  John A Gebe; Betty B Yue; Kelly A Unrath; Ben A Falk; Gerald T Nepom
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

10.  Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes.

Authors:  Martha Campbell-Thompson; Ann Fu; John S Kaddis; Clive Wasserfall; Desmond A Schatz; Alberto Pugliese; Mark A Atkinson
Journal:  Diabetes       Date:  2015-11-18       Impact factor: 9.461

View more
  54 in total

1.  Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances.

Authors:  Simi Ahmed; Karen Cerosaletti; Eddie James; S Alice Long; Stuart Mannering; Cate Speake; Maki Nakayama; Timothy Tree; Bart O Roep; Kevan C Herold; Todd M Brusko
Journal:  Diabetes       Date:  2019-07       Impact factor: 9.461

Review 2.  Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes.

Authors:  Stuart I Mannering; Anthony R Di Carluccio; Colleen M Elso
Journal:  Diabetologia       Date:  2018-11-06       Impact factor: 10.122

Review 3.  Immune Mechanisms and Pathways Targeted in Type 1 Diabetes.

Authors:  Laura M Jacobsen; Brittney N Newby; Daniel J Perry; Amanda L Posgai; Michael J Haller; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2018-08-30       Impact factor: 4.810

4.  A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen.

Authors:  Rizwan Ahmed; Zahra Omidian; Adebola Giwa; Benjamin Cornwell; Neha Majety; David R Bell; Sangyun Lee; Hao Zhang; Aaron Michels; Stephen Desiderio; Scheherazade Sadegh-Nasseri; Hamid Rabb; Simon Gritsch; Mario L Suva; Patrick Cahan; Ruhong Zhou; Chunfa Jie; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cell       Date:  2019-05-30       Impact factor: 41.582

Review 5.  NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP).

Authors:  Klaus H Kaestner; Alvin C Powers; Ali Naji; Mark A Atkinson
Journal:  Diabetes       Date:  2019-05-24       Impact factor: 9.461

Review 6.  The challenge of modulating β-cell autoimmunity in type 1 diabetes.

Authors:  Mark A Atkinson; Bart O Roep; Amanda Posgai; Daniel C S Wheeler; Mark Peakman
Journal:  Lancet Diabetes Endocrinol       Date:  2018-10-24       Impact factor: 32.069

Review 7.  Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction.

Authors:  L Peters; A Posgai; T M Brusko
Journal:  Clin Exp Immunol       Date:  2019-08-14       Impact factor: 4.330

Review 8.  Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".

Authors:  Sally C Kent; Stuart I Mannering; Aaron W Michels; Jenny Aurielle B Babon
Journal:  Curr Diab Rep       Date:  2017-09-02       Impact factor: 4.810

Review 9.  Next-generation regulatory T cell therapy.

Authors:  Leonardo M R Ferreira; Yannick D Muller; Jeffrey A Bluestone; Qizhi Tang
Journal:  Nat Rev Drug Discov       Date:  2019-09-20       Impact factor: 84.694

10.  High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.

Authors:  Annemieke de Jong; Ali Jabbari; Zhenpeng Dai; Luzhou Xing; Dustin Lee; Mei Mei Li; Madeleine Duvic; Maria Hordinsky; David A Norris; Vera Price; Julian Mackay-Wiggan; Raphael Clynes; Angela M Christiano
Journal:  JCI Insight       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.